<DOC>
	<DOC>NCT00819767</DOC>
	<brief_summary>This study compared the blunting effect of aliskiren and valsartan monotherapies on exercise-induced rises in systolic blood pressure in patients with mild to moderate essential hypertension.</brief_summary>
	<brief_title>Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Inclusion criteria: Mean sitting systolic blood pressure ≥ 140 mmHg and &lt; 180 mmHg measured at rest Patients able to exercise and to reach 85% of their predicted heart rate during a standard exercise test on a treadmill according to the Bruce Protocol Exclusion criteria: Patients not confident in exercising or not able to exercise Absolute contraindication to exercise Mean sitting systolic blood pressure ≥ 180 mmHg and/or mean sitting diastolic blood pressure ≥ 110 mmHg measured at rest Other protocoldefined inclusion/exclusion criteria applied to the study.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>systolic blood pressure</keyword>
	<keyword>exercise test</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>aliskiren</keyword>
	<keyword>valsartan</keyword>
</DOC>